Breaking
EMPO HEALTH RAISES $7M LED BY STORY VENTURES (JUN 2025) FDA-LISTED FOOTPRINT IMAGING SCALE NOW SHIPPING $80B / YEAR - WHAT DIABETIC FOOT ULCERS COST AMERICA 20M+ AMERICANS WITH DIABETIC NEUROPATHY ARE AT RISK PILOT STUDY: NEAR-DAILY ADHERENCE, EARLY ULCER SIGNS IN 50% EMPO HEALTH RAISES $7M LED BY STORY VENTURES (JUN 2025) FDA-LISTED FOOTPRINT IMAGING SCALE NOW SHIPPING $80B / YEAR - WHAT DIABETIC FOOT ULCERS COST AMERICA 20M+ AMERICANS WITH DIABETIC NEUROPATHY ARE AT RISK PILOT STUDY: NEAR-DAILY ADHERENCE, EARLY ULCER SIGNS IN 50%
Vol. 01 · The Profile · San Bruno, CA

Empo
Health

A bathroom scale that photographs your feet, ships the pictures to your doctor, and may keep your toes attached.

The Empo Footprint imaging scale installed in a patient's home
CaptionThe Footprint, mid-install. A scale on the outside, a clinic on the inside. One step is all it asks.
$7M
Raised, June 2025
$15M
Total To Date
29
Employees
2020
Founded

At 6:42 a.m. in a quiet bathroom in Ohio, a 64-year-old man with Type 2 diabetes brushes his teeth, looks at the small white slab beside the bathmat, and steps on. Ten seconds later, in San Bruno, California, his podiatrist receives a high-resolution photo of the bottom of his feet.

The slab is the Empo Footprint, an FDA-listed imaging scale that looks unremarkable on purpose. Underneath the matte plastic sits a camera array and a load cell, and behind that sits the Empo Remote Health Link - a HIPAA-compliant pipe that quietly couriers daily foot images and weight readings from a patient's home to a care team's dashboard.

The pitch is unromantic in the best way. Diabetic foot ulcers are the leading cause of non-traumatic amputation in the United States, and roughly 20 million Americans live with diabetic neuropathy that puts them at risk. The treatment guideline is daily foot checks. Almost nobody does them. Empo's bet is that habits beat heroics: if the screening is something you already do (step on a scale), the data follows by default.

A scale on the outside, a clinic on the inside. One step is all it asks.

Co-founder and CEO Anuj Khandelwal, a MIT and Stanford engineer who spent his early career at Amazon, built Empo Health in 2020 with co-founder Eric Dahlseng. The two had a thesis that consumer design - the kind that makes you stand on a scale every morning without thinking about it - could solve a chronic-disease compliance problem that no app, no patch, and no clinic appointment ever has.

It's a strange product to underestimate. The scale is cheerful, mint-branded, and modest. The numbers it stops are not. Diabetic foot ulcers consume up to $80 billion in US healthcare spending each year. The clinical pathway from an unnoticed callus to an amputation can run six to nine months. Catching the callus on day three is a different story.

All you have to do is briefly step on it once a day. — Empo Health, on the Footprint scale
The Product

Two things, working together quietly.

Hardware · FDA-listed

Empo Footprint

An imaging scale for the bathroom. Captures body weight and full-color, high-resolution images of both feet during a normal step-on. No buttons. No phone. No effort beyond the existing habit.

Software · HIPAA-compliant

Empo Remote Health Link

A monitoring service that ferries images and weight data from the home to the care team. Flags concerning changes, schedules follow-ups, and gives clinicians a longitudinal record that an in-office visit can't match.

How It Works

Three steps. One of them is literal.

Provider Prescribes

A podiatrist or endocrinologist enrolls a high-risk diabetic patient. The Footprint is shipped to the patient's home and set up next to the bathmat.

Patient Steps On

Each morning the patient stands on the scale for a few seconds. Weight is captured. So are full-color images of the soles of both feet.

Care Team Reviews

Images and weight trends flow through the Remote Health Link to clinicians. Concerning changes trigger an outreach before a callus becomes an ulcer.

The Founders

Engineers with a bathroom problem.

Co-Founder & CEO

Anuj Khandelwal

MIT undergrad, Stanford graduate, ex-Amazon. Built Empo around the conviction that consumer-grade design is the missing layer in chronic-disease hardware.

Co-Founder

Eric Dahlseng

Technical co-founder. Co-incorporated Empo in 2020 and helped take the Footprint scale from prototype to FDA-listed device.

The Money

$15M raised, quietly.

Capital Raised (cumulative, USD)

2020-2024 Pre-Seed/Seed
~$8M
2025 Round (Story Ventures)
$7M
Total to Date
$15M
Investors on the cap table Story Ventures (lead, 2025) · VTC Ventures · Ulu Ventures · SeaX Ventures · Arben Ventures · Gaingels · SBIR (NIH) grants · angel investors.
Latest Updates

What's happening.

  • Jun 2025Empo Health raises a $7M round led by Story Ventures and commercially launches the Footprint + Remote Health Link system. Total capital raised reaches $15M.
  • 2024-25Pilot study reports near-daily adherence and early ulcer signs detected in roughly half of enrolled patients - a striking number in a category defined by missed warnings.
  • 2020Empo Health incorporated by Anuj Khandelwal and Eric Dahlseng. Bay Area based. Backed early by Ulu Ventures and federal SBIR grants.
Coda

Back to the bathroom in Ohio.

It's 6:43 a.m. now. The man with Type 2 diabetes has finished brushing his teeth. He has not opened an app, not paired a sensor, not logged a symptom. The scale beside the bathmat already did all of that, in the time it took to step on and step off.

By 6:51 a.m. his podiatrist's dashboard in San Bruno will note a small change on the side of his left heel - the kind of change that, three months from now, in another timeline, would have meant a hospital admission. In this timeline, it means a phone call before lunch.

That is the scene Empo Health is quietly trying to make ordinary.

Share this profile